MannKind (MNKD) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist

6.540
-0.010-0.15%

Close Dec 13 16:00 ET

6.540
0.0000.00%

Post 20:01 ET

1.80BMarket Cap81.75P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | MannKind Corp: Expects to Ship Product for Cipla Ltd. by End of 2025
ReutersDec 11 06:05 ET
CDSCO Approves Afrezza (Insulin Human) Inhalation Powder in India
GlobeNewswireDec 11 06:00 ET
MannKind Corporation's (NASDAQ:MNKD) Institutional Investors Lost 3.9% Last Week but Have Benefitted From Longer-term Gains
Simply Wall StNov 28 08:44 ET
Insider Sale: Director at $MNKD (MNKD) Sells 67,536 Shares
Quiver QuantitativeNov 25 21:45 ET
Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7
MT NewswiresNov 14 12:56 ET · Ratings
Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Maintains Target Price $12
Moomoo NewsNov 12 08:33 ET · Ratings

Comments

BelleWeather

Nov 22 05:30

Housekeeping continued…

Surpassed target price and am focusing elsewhere.

Share Your Profit/Loss

BelleWeather

Oct 25 14:15

Scaling out

of LETFs and contracts…

Share Your Profit/Loss

BelleWeather

Oct 18 21:03

MannKind

I think this company still has room to grow and may be undervalued, however it is next to being scaling out for other opportunities as the space is crowded and many new therapies have advanced.

Share Your Profit/Loss

BelleWeather

Sep 23 16:26

Trading Plan on Shares

I think $United Natural Foods (UNFI.US)$
is still undervalued. Originally purchased as a longterm hold, I intend to sell instead at ~25 USD and put the capital toward other trades, likely CSPs focusing on other equities for longterm holds.
A speculative hold for the longterm, though may take profit if another opportunity beckons. This is the same approach as to $MannKind (MNKD.US)$ and $Iovance Biotherapeutics (IOVA.US)$ :
Two speculative positions that I am building (similar ...

Share Your Profit/Loss

BelleWeather

Sep 18 11:54

MannKind Calls

These calls performed well in theory, but I was unable to get a fill at maximum profit, which was about 90%. I’ve learned a realted lesson a few times. It’s key to trade options with a great deal of liquidity. (Or pay a fee for more obscure tickers, in order to get a more beneficial fill.) I now largely trade more popular contracts and use LEAPS to speculate in the longer term on less heavily traded equities; treating them as less capital intensive share proxies, to be traded at a ...

Heat List

Overall

No Data